BPA Call 36C24123A0032-36C24124N0346
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Veracyte, Inc., for the modification of the Decipher Prostate Cancer Testing service. The $64,811.80 contract has an ultimate completion date of November 14, 2026 and is not set aside. Veracyte, a for-profit medical diagnostics company, provides specialized genomic testing services to support precision medicine and personalized...
- This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract, valued at $194,435.40, is a Blanket Purchase Agreement (BPA) call order issued under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) contract vehicle. The contract is for Veracyte Labs to provide its proprietary Decipher Prostate Cancer Test, a genomic classifier that...
- This is a federal contract award to Veracyte, Inc., a for-profit medical diagnostics company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 (VISN 16). The contract is for $405,018.00 and involves the provision of genomic testing services, specifically Veracyte's proprietary genomic testing products and services. This is a firm fixed-price purchase order contract with a period of performance ending on May 31, 2029. The contract is not set aside and appears to...
- This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Veracyte, Inc., for the modification and delivery of the Decipher Prostate Cancer Testing service. The contract, valued at $64,811.80, is a Blanket Purchase Agreement (BPA) call placed under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract supports the VA's goal of providing personalized cancer care to...
- This is a firm fixed price contract awarded by the Veterans Health Administration's Veterans Integrated Service Network 8 (VISN 8) to Veracyte Labs SD Corporation, a division of Veracyte, Inc. The contract, valued at $372,667.85, is for the delivery of the Decipher Prostate Cancer Test, a specialized genomic diagnostic service that analyzes tumor gene expression patterns to help clinicians assess prostate cancer risk and guide treatment decisions. The contract is a Blanket Purchase Agreement...
- This is a firm fixed-price delivery order awarded to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 10. The $84,255.34 contract is for the company's Decipher Prostate Cancer Testing services, which provide genomic analysis to help clinicians make more informed treatment decisions for prostate cancer patients. Veracyte is a for-profit organization that specializes in advanced molecular...
- This is a federal contract award to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., for DECIPHER PROSTATE CANCER TESTING services. The contract, valued at $3,240.59, was awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA). This is a Firm Fixed Price Blanket Purchase Agreement (BPA) Call contract under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract does...
- This federal contract award, valued at $61,571.21, was issued by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract is a Blanket Purchase Agreement (BPA) call under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract is for the Decipher Prostate Cancer Testing service, which analyzes tumor gene expression patterns to help clinicians make more informed treatment...
- This federal contract award is for TESTING SERVICES- LAB provided by Veracyte Labs SD Corporation, a subsidiary of Veracyte, Inc. The contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) and does not have a set-aside designation. The contract, valued at $272,209.56, is a Delivery Order under Veracyte's existing Federal Supply Schedule contract for Medical Laboratory Testing and Analysis Services (FSS-621-II). Through this award, Veracyte...
- This federal contract award with ID 36C25722A0004|36C25723N0010 was made by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Veracyte, Inc., a for-profit organization that specializes in advanced molecular diagnostic services for cancer. The $38,887.08 firm fixed-price contract is for the Decipher Prostate Cancer Testing service under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). This contract supports the VA's...
- Medical Laboratory Testing and Analysis Services (FSS-621-II)Master GSA Schedule
- 36F79721D0019-36C24123A0032Blanket Purchase Agreement
- 36C24123A0032-36C24124N0346BPA Call
This is a federal contract award to Veracyte Labs SD Corporation, a division of Veracyte, Inc., for PROSTATE TESTING services. The $139,580.92 Blanket Purchase Agreement (BPA) Call contract is with the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 1 (VISN 1), and has a performance period ending on January 31, 2025. The contract was awarded on February 1, 2024 and is a Firm Fixed Price arrangement. Veracyte is a for-profit organization that specializes in advanced molecular diagnostic services, particularly genomic testing for prostate cancer. The company's core product, the Decipher Prostate Cancer Test, is used to analyze tumor gene expression patterns and help clinicians make more informed treatment decisions. This contract supports the VA's efforts to provide personalized, precision cancer care to veterans across various healthcare facilities. The award is not set aside for any specific business category, reflecting the specialized nature of Veracyte's genomic testing services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($250k) | 7/8/25 | |
| Not listed | Not listed | $390.0k | 1/18/24 |